Cargando…
Tetrazole and acylsulfonamide bioisosteric replacements of the carboxylic acid in a dual MCL-1/BCL-x(L) inhibitor are tolerated
Overexpression of the anti-apoptotic protein MCL-1 is associated with a plethora of human cancers, and it reduces the sensitivity of cancer cells to approved chemotherapies. Accordingly, the discovery of MCL-1 inhibitors is an active area of interest. Many inhibitors of the anti-apoptotic MCL-1 prot...
Autores principales: | Chen, Lijia, Lowe, Brandon, Fletcher, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664828/ https://www.ncbi.nlm.nih.gov/pubmed/38024975 http://dx.doi.org/10.1039/d3ra05711a |
Ejemplares similares
-
Practical scale up synthesis of carboxylic acids and their bioisosteres 5-substituted-1H-tetrazoles catalyzed by a graphene oxide-based solid acid carbocatalyst
por: Mittal, Rupali, et al.
Publicado: (2021) -
Functional and structural analyses of N-acylsulfonamide-linked dinucleoside inhibitors of RNase A
por: Thiyagarajan, Nethaji, et al.
Publicado: (2011) -
Extraction of useful bioisostere replacments from the PDB
por: Ritschel, T, et al.
Publicado: (2011) -
Workflow-based identification of bioisosteric replacements for molecular scaffolds
por: Höhfeld, Kerstin, et al.
Publicado: (2008) -
Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies
por: Melvold, Katrine, et al.
Publicado: (2021)